Anavex Life Sciences To Host Investor Call On Wednesday, September 9, 2026, At 4:00 PM ET
Anavex Investor Call Information:
- A link to the live webcast of the conference call will be available on Anavex's investor relations website at anavex.com/investors. The conference call can also be accessed by dialing 1-866-777-2509 for participants in the U.S. and Canada or 1-412-317-5413 for international participants. Participants should ask to join the Anavex call. A replay of the conference call will be available at anavex.com/investors shortly after the end of the call.
The Company is now current on its financial reporting obligations with the Securities and Exchange Commission and, on September 2, 2026, officially regained compliance with NASDAQ listing rules as a result of filing its outstanding Form 10-Qs for the second and third fiscal quarters for 2026.
About Anavex Life Sciences Corp.
Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded clinical stage biopharmaceutical company engaged in the development of novel therapeutics for the treatment of central nervous system diseases with high unmet medical need. Further information is available at .
Investor Relations & Media Contact:
SCR Partners, LLC
Alex Arzeno
Tel: 203-550-3972
Email:...
Tripp Sullivan
Tel: 615-942-7077
Email:...
Company Contact:
Sandra Boenisch
Principal Financial Officer
Anavex Life Sciences Corp.
Tel: 1-844-689-3939
Email: ...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment